Music for Chronic Pain
(MusKiP Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores whether listening to music can enhance the pain-relieving effects of IV ketamine in individuals with chronic pain. Ketamine, often used for difficult-to-treat pain, might be more effective when combined with music, particularly self-selected tunes. Participants will experience different music scenarios during ketamine sessions, such as their favorite songs, music chosen by a therapist, or no music, to determine which provides the best relief. This trial suits those with chronic non-cancer-related pain who already receive ketamine infusions at the Alan Edwards Pain Management Unit. As an unphased trial, it offers a unique opportunity to explore innovative pain management strategies.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. However, you must avoid grapefruit juice on the day of the ketamine infusions, as it can affect how the drug works.
Is there any evidence suggesting that this trial's treatments are likely to be safe?
Research has shown that music therapy can help reduce pain in individuals with chronic pain. For instance, one study found that music therapy lowered pain levels from 4.9 to 3.5 on a pain scale, even when participants were taking other pain medications. Another large study found that music therapy sessions focused on pain management could reduce pain by two or more points.
Researchers are studying the safety and effectiveness of listening to music during ketamine infusions. The music itself is generally safe and easy to manage. Ketamine, the main treatment, is already used in some medical settings, indicating its relative safety. However, ketamine can cause side effects like feeling disconnected from reality, so awareness of this is important.
Overall, previous studies have shown that music can aid in pain relief, and ketamine is a recognized treatment option. While music therapy is safe, monitoring the effects of ketamine during treatment is essential.12345Why are researchers excited about this trial?
Researchers are excited about exploring music as a treatment for chronic pain because it offers a non-invasive and drug-free alternative to standard pain management options like opioids, NSAIDs, and physical therapy. Unlike traditional medications that often carry risks of side effects and dependency, music therapy leverages the brain's natural response to sound to potentially reduce pain perception and improve mood. This trial aims to understand the specific impacts of preferred music, therapist-selected music, and silence on chronic pain, which could lead to personalized and accessible pain management strategies that enhance overall well-being without the downsides of medication.
What evidence suggests that this trial's treatments could be effective for chronic pain?
Research has shown that music therapy can help reduce long-term pain. A large study found that music therapy sessions focused on managing pain could lower pain levels by more than 2 points. Additionally, music therapy has reduced pain and anxiety when combined with regular painkillers. Another study found that live music therapy significantly lowered pain scores from 4.9 to 3.5. In this trial, participants will experience different sequences of music and silence, including preferred music, therapist-selected music, and silence. These findings suggest that music, especially when tailored to the individual, might enhance the pain-relieving effects of treatments like IV ketamine.23467
Who Is on the Research Team?
Mark A Ware, MD
Principal Investigator
McGill University Health Centre/Research Institute of the McGill University Health Centre
Mathieu Roy, PhD
Principal Investigator
McGill University
Are You a Good Fit for This Trial?
This trial is for chronic pain patients who are already receiving IV ketamine treatments at the Montreal General Hospital's pain clinic. Participants should be open to listening to music or silence during their infusions and willing to track their pain levels.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Baseline Infusion
Participants receive a baseline ketamine infusion under usual conditions to establish a baseline
Treatment
Participants undergo three ketamine infusion sessions with different music conditions: self-selected music, therapist-selected music, and silence
Follow-up
Participants are monitored for safety and effectiveness after treatment, with pain intensity ratings collected over a 5-week period
What Are the Treatments Tested in This Trial?
Interventions
- Music
Find a Clinic Near You
Who Is Running the Clinical Trial?
McGill University
Lead Sponsor
McGill University Health Centre/Research Institute of the McGill University Health Centre
Collaborator